{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:44:47Z","timestamp":1754163887654,"version":"3.41.2"},"reference-count":18,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2023,1,21]]},"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1136\/thorax-2022-219979","type":"journal-article","created":{"date-parts":[[2023,3,16]],"date-time":"2023-03-16T06:25:53Z","timestamp":1678947953000},"page":"430-431","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["ICS\/formoterol maintenance and reliever therapy: how far beyond asthma?"],"prefix":"10.1136","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0337-406X","authenticated-orcid":false,"given":"Richard","family":"Beasley","sequence":"first","affiliation":[{"name":"Medical Research Institute of New Zealand, Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pepa","family":"Bruce","sequence":"additional","affiliation":[{"name":"Medical Research Institute of New Zealand, Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2062-7225","authenticated-orcid":false,"given":"Lee","family":"Hatter","sequence":"additional","affiliation":[{"name":"Medical Research Institute of New Zealand, Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"2025073109050640000_78.5.430.1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.2769"},{"key":"2025073109050640000_78.5.430.2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-2600(13)70007-9","article-title":"Efficacy and safety of maintenance and reliever combination budesonide-formoterol inhaler in patients with asthma at risk of severe exacerbations: a randomised controlled trial","volume":"1","author":"Patel","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2025073109050640000_78.5.430.3","unstructured":"Global Initiative for Asthma (GINA) . Global strategy for asthma management and prevention. 2022. Available: http:\/\/www.ginasthma.org\/ [Accessed 10 Jan 2021]."},{"key":"2025073109050640000_78.5.430.4","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/resp.14325","article-title":"Treatable traits in the novelty study","volume":"27","author":"Agust\u00ed","year":"2022","journal-title":"Respirology"},{"key":"2025073109050640000_78.5.430.5","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.1.59"},{"key":"2025073109050640000_78.5.430.6","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/thorax-2022-219620","article-title":"Budesonide\/formoterol maintenance and reliever therapy versus fluticasone\/salmeterol fixed-dose treatment in patients with COPD","volume":"78","author":"Muiser","year":"2023","journal-title":"Thorax"},{"key":"2025073109050640000_78.5.430.7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063070"},{"key":"2025073109050640000_78.5.430.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200707-973OC"},{"key":"2025073109050640000_78.5.430.9","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1916046"},{"key":"2025073109050640000_78.5.430.10","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-202872"},{"key":"2025073109050640000_78.5.430.11","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.10.1247"},{"key":"2025073109050640000_78.5.430.12","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2011.160028"},{"key":"2025073109050640000_78.5.430.13","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-2137"},{"key":"2025073109050640000_78.5.430.14","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00037-2017","article-title":"The risk of mycobacterial infections associated with inhaled corticosteroid use","volume":"50","author":"Brode","year":"2017","journal-title":"Eur Respir J"},{"key":"2025073109050640000_78.5.430.15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41533-019-0150-x","article-title":"Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study","volume":"29","author":"Price","year":"2019","journal-title":"NPJ Prim Care Respir Med"},{"key":"2025073109050640000_78.5.430.16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201810-1868CI"},{"key":"2025073109050640000_78.5.430.17","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01219-2018","article-title":"Inhaled corticosteroids in COPD: friend or foe?","volume":"52","author":"Agusti","year":"2018","journal-title":"Eur Respir J"},{"key":"2025073109050640000_78.5.430.18","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S175047"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2022-219979","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T16:05:18Z","timestamp":1753977918000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2022-219979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":18,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,4,13]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/thorax-2022-219979"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2022-219979","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"type":"print","value":"0040-6376"},{"type":"electronic","value":"1468-3296"}],"subject":[],"published":{"date-parts":[[2023,3,2]]}}}